Arkansas officials and lawmakers say a nearly $1.2 billion fine levied on Johnson & Johnson and a subsidiary would help the state solve a looming shortfall in its Medicaid program, but they're not counting on the money just yet.

Gov. Mike Beebe's office and the Department of Human Services said Thursday it's premature for the state to plan for the money awarded a day earlier by a Pulaski County judge. The fine was imposed after a jury found the companies downplayed and hid risks associated with an antipsychotic drug.

The state was awarded the money as it faces a shortfall of up to $400 million in its Medicaid program beginning in July 2013. Beebe's office said if the state ultimately receives the money, the program will still need long-term changes.

Risperdal,Zyprexa,as well as the other atypical antipsychotics, are being prescribed for children, even though this is an unapproved, off-label use. An estimated 2.5 million children are now taking atypical antipsychotics. Over half are being given them for Attention Deficit Hyperactivity Disorder,many of these foster children.